8-Iso-Prostaglandin F2α and Metabolic Syndrome
What is it about?
It has been reported that oxidative stress is associated with metabolic syndrome. We have examined whether urinary 8-iso-prostaglandin F2α (8-iso-PGF2α) is a reliable marker of the accumulation of metabolic risks in a cross-sectional study of the baseline characteristics of a Japanese general population cohort study: Research on Osteoarthritis/Osteoporosis Against Disability (ROAD).
Why is it important?
Our findings show that urinary 8-iso-PGF2a can be a reliable marker of impaired glucose tolerance and the accumulation of metabolic risks, especially in younger people.
The following have contributed to this page: Dr Kanae Mure and Dr. Sakae Tanaka
In partnership with: